ABSTRACT
I
NTERFERON-t (IFN-t) IS A MEMBER of the type I IFN family that also includes IFN-a, IFN-b, and IFN-v. The closest member of the family is IFN-v, which has 75% amino acid identity with IFN-t and, like IFN-t, is 172 amino acids in length.
(1) IFN-t evolved from IFN-v about 36 million years ago (2) after the divergence of pecoran ruminants from other artiodactyls. Because of their recent evolution, genes for IFN-t are found only in pecoran ruminants, such as sheep, cattle, goats, deer, and giraffes. (2, 3) Tissue expression of IFN-t is unique among IFN, as it is secreted only by the trophectoderm of periattachment conceptuses for a limited period in early pregnancy. Peak secretion, which occurs around days 12-17 in sheep, (4, 5) and days 15-25 in cattle, (5, 6) is coincident with the period when the uterus would ordinarily secrete luteolytic amounts of prostaglandin F 2a (PGF 2a ). Indeed, its primary role in pregnancy is to inhibit the pulsatile release of PGF 2a from the uterus to allow continued survival of the corpus luteum and the maintenance of pregnancy. (7, 8) IFN-t also differs from other IFN in that gene expression is not highly inducible by virus but rather is expressed constitutively within the trophectoderm. (9) Nonetheless, IFN-t possesses many biologic activities characteristic of other type I IFN, such as antiviral (10) (11) (12) (13) and antiproliferative (10) (11) (12) (14) (15) (16) activities, and the ability to induce expression of genes that are normally regulated by other type I IFN, such as 29,59-oligoadenylate synthetase, (17) granulocyte chemotactic protein-2, (18) ubiquitin cross-reactive protein, (19) Mx protein, (20) and IFN regulatory factor-1 (IRF-1) and IRF-2. (21) Among the immune cells whose growth is inhibited by IFN-t are peripheral blood lymphocytes (PBL) (10, 14, 15) and WC1 1 CD8 2 gd T cells. (22) IFN-t can stimulate expansion of WC1 2 CD8 1 gd T cells (22) and increase the cytotoxic activity of sheep and pig natural killer (NK) cells. (23) Regulation of lymphocyte growth and activation may be important for preventing rejection of the allogeneic conceptus, which in the sheep is susceptible to lysis by lymphokine-activated killer (LAK) cells, (24) or for determining the amount and nature of lymphocyte-derived cytokines capable of regulating conceptus function. (25) Immunoregulation of uterine lymphocytes by IFN-t is indicated by the observation in cattle that during pregnancy, maximal IFN-t secretion is associated with a decrease in the number of intraepithelial lymphocytes in the endometrium. equal in relative abundance. (13) OvIFN-t4 is the most potent antiviral IFN-t (12, 13, 33) and is more potent than IFN-t6d and IFN-t11 in inhibiting growth of human Daudi cells. (12) Moreover, the IFN-t variants have different potencies in eliciting antiluteolytic actions, with IFN-t4 being more effective at extending the life span of the corpus luteum than IFN-t6d, IFN-t2c, and IFN-t11. (12, 13) The objective of this study was to compare IFN-t variants for their potency in ability to inhibit mitogen-induced proliferation of sheep PBL. Demonstration that IFN-t variants differ in biologic activity would imply that the immunoregulatory actions of the conceptus during the periimplantation period would depend on the mix of IFN-t variants secreted by the trophoblast.
For the experiment, adult cycling ewes of predominantly Rambouillet genotype were used as blood donors. Tissue culture medium-199 (TCM-199), Eagle's minimal essential medium (MEM), glutamine, penicillin-streptomycin, phytohemagglutinin-L (PHA), red cell lysis buffer, b-mercaptoethanol, and Triton-X 100 were purchased from Sigma Chemical (St. Louis, MO). Fico-Lite-1077 was from Atlanta Biologicals (Norcross, GA). Horse serum was from HyClone (Logan, UT). Fetal bovine serum (FBS) was from Intergen (Purchase, NY). [ 3 H]Methyl thymidine (specific activity 670 mCi/mmol) was from Amersham Life Sciences (Piscataway, NJ). Cell culture flasks were from Sarstedt (Newton, NC), and 96-well culture plates were from Becton Dickinson (River Falls, NJ). Production and purification of recombinant IFN-t4, IFNt6d, and IFN-t11 were performed as previously described. (12) The OvIFN-v (see ref. Cells were fermented in Luria broth containing ampicillin (50 mg/ml) and chloramphenicol (17 mg/ml) at 37°C. Recombinant protein expression was induced at the proper cell density (OD 600 5 1.0) with 0.5 mM isopropyl-a-D-thiogalactoside (IPTG) (AlexisCorp., San Diego, CA). After 6 h, cells were collected and lysed, and insoluble proteins were isolated and refolded as described previously. (29) Approximately 90% of the resulting protein preparation was estimated to represent OvIFNv, as determined visually after SDS-PAGE and Coomassie staining.
Antiviral activity of each recombinant protein was determined as the ability of IFN to inhibit vesicular stomatitis virus (VSV)-induced cytolysis of Madin-Daily bovine kidney (MDBK) cells. (10) One antiviral unit of recombinant OvIFN (rOvIFN) was defined as the concentration of IFN that prevented cytolysis by 50%. Using this measure, antiviral activity was 178.21 pM for IFN-t4, 609.5 pM for IFN-t6d, 330.2 pM for IFN-t11, and 1592 pM for IFN-v.
PBL were obtained by fractionation of heparinized whole blood from adult cyclic ewes using density gradient centrifugation on Fico-Lite-1077. Cells were washed two times in 2 ml TCM-199 and resuspended at 1 3 10 6 cells/ml in modified TCM-199 (TCM-199 containing 5% [v/v] horse serum, 200 U/ml penicillin, 0.2 mg/ml streptomycin, 2 mM extra glutamine, and 10 25 M b-mercaptoethanol). Briefly, 1 3 10 5 PBL in 100 ml total volume were placed in individual wells of 96-well culture plates with various concentrations of IFN-t variants and 2 mg PHA (dissolved in DPBS; volume 10 ml) in a final volume of 170 ml modified TCM-199. For control wells, an equivalent volume of DPBS was added instead of IFN. After cells were incubated at 37°C and 5% CO 2 for 72 h, [ 3 H]thymidine (0.1 mCi/well) was added in 30 ml modified TCM-199. Cells were incubated overnight at 37°C and 5% CO 2 and then harvested onto glass-fiber filters using a cell harvester (Brandel, Gaithersburg, MD) and consecutive washes with 0.9% (w/v) NaCl and distilled water. The amount of [ 3 H]thymidine on the filters was measured using a liquid scintillation counter (LKB Wallac Model 1219, Turku, Finland).
In the first experiment, IFN-t variants were tested at final concentrations (i.e., after addition of [ 3 H]thymidine) of 1, 10, and 10 ng/ml). The experiment was replicated three times with PBL from a different ewe for each replicate. The second experiment was conducted similarly except that concentrations of 20, 60, and 100 ng/ml IFN-t were tested. For the last experiment, concentrations of IFN-t6d, IFN-t11, and IFN-v were tested at antiviral units equivalent to antiviral activity of 1, 10, and 20 ng/ml of IFN-t4. Thus, IFN-t6d (3.42 times less potent than IFN-t4) was tested at 3.42, 34.2, and 68.4 ng/ml, IFN-t11 (1.86 times less potent than IFN-t4) was tested at 1.86, 18.6, and 37.2 ng/ml, and IFN-v (8.94 times less potent than IFNt4) was tested at 8.94, 89.4, and 178.8 ng/ml. The experiment was replicated three times with PBL from a different ewe for each replicate.
Data were analyzed by least squares analysis of variance using the general linear models procedure of the Statistical Analysis System. (34) Ewe was considered a random effect, and other main effects were considered as fixed. Differences in proliferation between control lymphocytes and individual concentrations of each IFN were determined by the pdiff mean separation test of SAS. To determine differences in potency of individual IFN, the dataset was restricted to exclude data for control lymphocytes, and orthogonal contrasts were used to determine differences between IFN. The contrasts were IFN-t4 vs. others, IFNt6d 1 IFN-t11 vs. IFN-v, and IFN-t6d vs. IFN-t11.
Results of the first two experiments are shown in Figure 1 . When IFN-t variants were tested at 1, 10, and 20 ng/ml, all concentrations of each IFN-t variant inhibited [ 3 H]thymidine uptake by PHA-stimulated PBL (p , 0.05). However, IFN-t4 was more inhibitory than either IFN-t6d, IFN-t11, or an IFNv control (treatment 3 concentration; p , 0.03) (Fig. 1, left) . A similar result was obtained when IFN-t variants were tested at concentrations of 20, 60, and 100 ng/ml (Fig. 1, right) . All concentrations of each IFN inhibited [ 3 H]thymidine uptake (p , 0.025), IFN-t4 was more inhibitory than the other IFN (p , 0.001), and IFN-v was the least inhibitory (IFN-v vs. IFNt6d 1 IFN-t11 ; p , 0.001). The inhibition of proliferation was dose dependent. However, inhibition plateaued at 60 ng/ml, and the addition of 100 ng/ml did not cause further inhibition. Moreover, at the highest concentrations tested, inhibition was only , 50% for IFN-t4, 36% for IFN-t6d, 31.5% for IFN-t11, and 15% for IFN-v.
Differences in activity of IFN-t variants were also apparent when concentrations of each IFN were adjusted for their antiviral activity (Fig. 2) . Again, all concentrations of each IFN inhibited [ 3 H]thymidine uptake (p , 0.001). However, even though concentrations of IFN were adjusted for differences in antiviral potency, IFN-t4 was more inhibitory than other IFN (p , 0.01), and IFN-v was the least inhibitory (p , 0.02).
It has been reported previously that OvIFN-t variants showed differences in antiviral and antiluteolytic activity, (11) (12) (13) 33, 35) with IFN-t4 being the most active variant. Parallel to these reports, present results indicate that IFN-t variants IFN-t4, IFNt6d, IFN-t11, and IFN-v vary in effectiveness in inhibiting PHA-induced proliferation of lymphocytes, with IFN-t4 being the most potent inhibitor among the variants tested. Fillion et al. (31) previously showed that five variants of IFN-t purified from conditioned medium of cultured sheep conceptuses were immunosuppressive toward PHA-induced lymphocyte proliferation. However, differences among these variants in inhibiting proliferation were not evaluated.
Differences in potency of lymphocyte inhibition between IFN-t variants were not simply a reflection of differences in receptor affinity. This is because IFN-t4 inhibited a greater proportion of lymphocyte proliferation when variants were tested at saturating concentrations of IFN-t or when variants were tested at the same antiviral concentration. These observations suggest that some populations of lymphocytes are capable of responding to IFN-t4 but not to IFN-t6d, IFN-t11, and IFNv. Failure of some lymphocyte populations to be inhibited by IFN-t is probably not because of lack of receptor expression, given the near ubiquitous distribution of the type I IFN receptor. (36) Inhibition of proliferation by IFN-a requires components of the T cell receptor (TCR) complex. (37) Perhaps the assembly of the complex among IFN-t, type I receptor, and other proteins required for signal transduction is favored for some IFNt variants in a cell type-specific manner. There is evidence that the specific signal transduction pathway varies between IFN-a and IFN-b (38) and between HuIFN-a4a and HuIFN-a2a. (39) In the uterus, too, there is evidence that the nature of the response to type I IFN depends on IFN type. Although IFN-t and IFNa have the same receptor in the endometrium, only IFN-t induces granulocyte chemotactic protein-2 gene expression. (18) The well-studied observation that IFN-t, like other type I IFN, can inhibit lymphocyte proliferation (14, 15, 31) has been interpreted to indicate that one function of IFN-t is to block maternal lymphocyte responses directed against the conceptus. Consistent with this finding is the observation that numbers of intraepithelial lymphocytes in the luminal epithelium decline from day 20 until day 27 of pregnancy, following the period of maximal IFN-t secretion. (22) However, this interpretation might be oversimplified, as type I IFN have been shown to augment skin allograft rejection (40, 41) and activate NK cells, (23) actions that could compromise immunotolerance toward the conceptus. The nature of the effect of IFN-t probably depends on the particular lymphocytes in the uterine epithelium. For example, IFN-t stimulates WC1 2 CD8 1 gd T cells and suppresses WC1 1 CD8 2 gd T cells. (22) In conclusion, sheep trophectoderm secretes variants of IFNt that differ in their ability to regulate maternal lymphocyte function. Thus, the nature of the effect of the trophectoderm on endometrial lymphocytes may depend on the type and the relative amounts of each IFN-t variant produced during pregnancy.
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